Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR1432343

GTEX

ba5819b4-3e81-5772-92fa-76830eb777c0

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Male

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • KRAS_SIGNALING_DN+0.358
  • SPERMATOGENESIS+0.334
  • HEDGEHOG_SIGNALING+0.176
  • MYOGENESIS+0.134
  • PANCREAS_BETA_CELLS+0.020
  • ESTROGEN_RESPONSE_LATE-0.027
  • ESTROGEN_RESPONSE_EARLY-0.041
  • UV_RESPONSE_DN-0.055
  • APICAL_SURFACE-0.059
  • BILE_ACID_METABOLISM-0.080

Top 10 suppressed

  • MYC_TARGETS_V1-0.563
  • INTERFERON_ALPHA_RESPONSE-0.514
  • MTORC1_SIGNALING-0.489
  • DNA_REPAIR-0.468
  • E2F_TARGETS-0.460
  • UNFOLDED_PROTEIN_RESPONSE-0.460
  • PROTEIN_SECRETION-0.458
  • INTERFERON_GAMMA_RESPONSE-0.454
  • G2M_CHECKPOINT-0.435
  • MYC_TARGETS_V2-0.427

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR1406561
brain-umap@2
GTEX0.988
2SRR1325986
brain-umap@2
GTEX0.975
3SRR1385080
brain-umap@2
GTEX0.972
4SRR602927
brain-umap@2
GTEX0.970
5SRR1466850
brain-umap@2
GTEX0.968
6SRR1336357
brain-umap@2
GTEX0.967
7SRR1315269
brain-umap@2
GTEX0.967
8SRR1403050
brain-umap@2
GTEX0.967
9SRR1443824
brain-umap@2
GTEX0.966
10SRR1335254
brain-umap@2
GTEX0.965

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 5 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
KRAS_SIGNALING_DN0.358Remibrutinib— uncovered
SPERMATOGENESIS0.334Inavolisib— uncovered
HEDGEHOG_SIGNALING0.176Inavolisib— uncovered
MYOGENESIS0.134Inavolisib— uncovered
PANCREAS_BETA_CELLS0.020Cobimetinib— uncovered